Phase I study of sapanisertib (CB‐228/TAK‐228/MLN0128) in combination with ziv‐aflibercept in patients with advanced solid tumors. - Coleman, Niamh; Stephen, Bettzy; Fu, Siqing; Karp, Daniel; Subbiah, Vivek; Ahnert, Jordi Rodon; Piha‐Paul, Sarina A.; Wright, John; Fessahaye, Senait N.; Ouyang, Fengying; Yilmaz, Bulent; Meric‐Bernstam, Funda; et al. (Cancer Medicine, 2024)